A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4
This study aimed to establish a lncRNA-based signature for predicting the prognosis of patients with high stage and grade renal cell carcinoma (RCC). According to the Surveillance, Epidemiology, and End Results (SEER) database, sex, age, grade, stage, surgery, chemotherapy, radiation, tumor size, an...
Main Authors: | Ning Li, Haiying Zhang, Keyao Hu, Jianfeng Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Bioengineered |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21655979.2021.1971022 |
Similar Items
-
A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01) -
A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma
by: Ji Chen, et al.
Published: (2021-06-01) -
A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
by: Wen Jiang, et al.
Published: (2019-08-01) -
Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
by: Lan zhang, et al.
Published: (2020-08-01) -
A seven-lncRNA signature for predicting Ewing’s sarcoma
by: Zhihui Chen, et al.
Published: (2021-06-01)